CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-30 | Yurasov Sergey CHIEF MEDICAL OFFICER | Grant or award | +75,000 | 75,000 | ||
| 2025-01-30 | Yurasov Sergey CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-01-30 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Grant or award | +75,000 | 170,192 | ||
| 2025-01-30 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-01-30 | Jones Erika SEE REMARKS | Grant or award | +75,000 | 85,150 | ||
| 2025-01-30 | Jones Erika SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-01-30 | Hatzis-Schoch Brent SEE REMARKS | Grant or award | +75,000 | 83,400 | ||
| 2025-01-30 | Hatzis-Schoch Brent SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2024-12-13 | Raman Prakash Director | Grant or award | +5,150 | $2.50 | $13K | 10,145 |
| 2024-12-13 | Campbell Shannon Director | Grant or award | +4,500 | $2.50 | $11K | 8,865 |
| 2024-12-13 | Behbahani Ali Director | Grant or award | +5,750 | $2.50 | $14K | 63,334 |
| 2024-09-20 | Campbell Shannon Director | Grant or award | +2,354 | $4.78 | $11K | 4,365 |
| 2024-09-20 | Raman Prakash Director | Grant or award | +2,694 | $4.78 | $13K | 4,995 |
| 2024-09-20 | Behbahani Ali Director | Grant or award | +3,007 | $4.78 | $14K | 57,584 |
| 2024-08-28 | Versant Venture Capital VI, L.P. 10% owner | Sale | −221,600 | $6.32 | $1.4M | 3,726,341 |
| 2024-06-21 | Raman Prakash Director | Grant or award | +2,301 | $4.98 | $11K | 2,301 |
| 2024-06-21 | Campbell Shannon Director | Grant or award | +2,011 | $4.98 | $10K | 2,011 |
| 2024-06-21 | Behbahani Ali Director | Grant or award | +2,887 | $4.98 | $14K | 54,577 |
| 2024-06-06 | Kulkarni Samarth Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 | ||
| 2024-06-06 | Menzel Garry E Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 |
Page 3 of 6 · 114 trades